These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6086823)

  • 21. Potential sites of virus latency associated with indigenous pseudorabies viruses in feral swine.
    Romero CH; Meade PN; Homer BL; Shultz JE; Lollis G
    J Wildl Dis; 2003 Jul; 39(3):567-75. PubMed ID: 14567217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction and characterization of deletion mutants of pseudorabies virus: a new generation of 'live' vaccines.
    Quint W; Gielkens A; Van Oirschot J; Berns A; Cuypers HT
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():523-34. PubMed ID: 3029289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel intergenic site for integration and expression of foreign genes in the genome of pseudorabies virus.
    Fuchs W; Bauer B; Mettenleiter TC; Rziha HJ
    J Virol Methods; 1994 Jan; 46(1):95-105. PubMed ID: 8175950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudorabies virus infections in pigs. Role of viral proteins in virulence, pathogenesis and transmission.
    Mulder WA; Pol JM; Gruys E; Jacobs L; De Jong MC; Peeters BP; Kimman TG
    Vet Res; 1997; 28(1):1-17. PubMed ID: 9172836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of markers for virulence in the unique short region or repeat region or both of pseudorabies hybrid viruses.
    Berns A; van den Ouweland A; Quint W; van Oirschot J; Gielkens A
    J Virol; 1985 Jan; 53(1):89-93. PubMed ID: 2981366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the equalization of inverted repeats and neurovirulence using a pseudorabies virus mutant strain altered at the Ul/Ir junction.
    Boldogköi Z; Braun A; Medveczky I; Glávits R; Gyúró B; Fodor I
    Virus Genes; 1998; 17(1):89-98. PubMed ID: 9778792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine.
    Mettenleiter TC; Klupp BG; Weiland F; Visser N
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1723-33. PubMed ID: 8021601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic variations among wildtype and mutant strains of pseudorabies virus.
    Zeenathul NA; Mohd-Azmi ML; Ali AS; Aini I; Sheik-Omar AR; Abdul-Rahim AM; Bahaman AR; Kamarudin AI
    Rev Argent Microbiol; 2002; 34(1):7-14. PubMed ID: 11942085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome location and identification of functions defective in the Bartha vaccine strain of pseudorabies virus.
    Lomniczi B; Watanabe S; Ben-Porat T; Kaplan AS
    J Virol; 1987 Mar; 61(3):796-801. PubMed ID: 3027406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A deletion at the UL/IR junction reduces pseudorabies virus neurovirulence.
    Dean HJ; Cheung AK
    J Virol; 1995 Feb; 69(2):1334-8. PubMed ID: 7815517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deletions in the genomes of pseudorabies virus vaccine strains and existence of four isomers of the genomes.
    Lomniczi B; Blankenship ML; Ben-Porat T
    J Virol; 1984 Mar; 49(3):970-9. PubMed ID: 6321776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nucleotide sequences at recombinational junctions present in pseudorabies virus variants with an invertible L component.
    Lu ZQ; DeMarchi JM; Harper L; Rall GF; Ben-Porat T
    J Virol; 1989 Jun; 63(6):2690-8. PubMed ID: 2542582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of pseudorabies viruses recently isolated in Japan by restriction endonuclease assay.
    Yamada S; Nishimori T; Shimizu M
    J Vet Med Sci; 1992 Jun; 54(3):541-9. PubMed ID: 1322717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specificity and nucleotyping studies of a gp50-based polymerase chain reaction assay for detection of pseudorabies virus.
    Harding MJ; Prud'homme I; Rola J
    Can J Vet Res; 1997 Apr; 61(2):157-60. PubMed ID: 9114968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. cis Functions involved in replication and cleavage-encapsidation of pseudorabies virus.
    Wu CA; Harper L; Ben-Porat T
    J Virol; 1986 Aug; 59(2):318-27. PubMed ID: 3016300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudorabies virus can escape from CRISPR-Cas9-mediated inhibition.
    Peng Z; Ouyang T; Pang D; Ma T; Chen X; Guo N; Chen F; Yuan L; Ouyang H; Ren L
    Virus Res; 2016 Sep; 223():197-205. PubMed ID: 27507009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of sites of pseudorabies virus latency, using polymerase chain reaction.
    Wheeler JG; Osorio FA
    Am J Vet Res; 1991 Nov; 52(11):1799-803. PubMed ID: 1664672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restriction endonuclease analysis of Aujeszky's disease (pseudorabies) virus DNA: comparison of Northern Ireland isolates and isolates from other countries.
    Todd D; McFerran JB
    Arch Virol; 1985; 86(3-4):167-76. PubMed ID: 2998299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ribonucleotide reductase-deficient mutants of pseudorabies virus are avirulent for pigs and induce partial protective immunity.
    de Wind N; Berns A; Gielkens A; Kimman T
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():351-9. PubMed ID: 8383170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of changes in the short unique segment of pseudorabies virus BUK-TK900 (Suivac A) vaccine strain.
    Ficińska J; Bieńkowska-Szewczyk K; Jacobs L; Płucienniczak G; Płucienniczak A; Szewczyk B
    Arch Virol; 2003 Aug; 148(8):1593-612. PubMed ID: 12898333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.